Dysregulated B Cell Expression of RANKL and OPG Correlates with Loss of Bone Mineral Density in HIV Infection
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
HIV infection is associated with high rates of osteopenia and osteoporosis, but the mechanisms involved are unclear. We recently reported that bone loss in the HIV transgenic rat model was associated with upregulation of B cell expression of the key osteoclastogenic cytokine receptor-activator of NF-κB ligand (RANKL), compounded by a simultaneous decline in expression of its physiological moderator, osteoprotegerin (OPG). To clinically translate these findings we performed cross-sectional immuno-skeletal profiling of HIV-uninfected and antiretroviral therapy-naïve HIV-infected individuals. Bone resorption and osteopenia were significantly higher in HIV-infected individuals. B cell expression of RANKL was significantly increased, while B cell expression of OPG was significantly diminished, conditions favoring osteoclastic bone resorption. The B cell RANKL/OPG ratio correlated significantly with total hip and femoral neck bone mineral density (BMD), T- and/or Z-scores in HIV infected subjects, but revealed no association at the lumbar spine. B cell subset analyses revealed significant HIV-related increases in RANKL-expressing naïve, resting memory and exhausted tissue-like memory B cells. By contrast, the net B cell OPG decrease in HIV-infected individuals resulted from a significant decline in resting memory B cells, a population containing a high frequency of OPG-expressing cells, concurrent with a significant increase in exhausted tissue-like memory B cells, a population with a lower frequency of OPG-expressing cells. These data validate our pre-clinical findings of an immuno-centric mechanism for accelerated HIV-induced bone loss, aligned with B cell dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962 · cited 2×
“Because OPG and RANKL are considered key downstream effectors of osteoclast formation and bone resorption [17,18], we quantified plasma concentrations of soluble total RANKL and OPG in HIV-infected and HIV-negative individuals.”
BackgroundPD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Minireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515 · cited 2×
“Because OPG and RANKL are considered key downstream effectors of osteoclast formation and bone resorption [17,18], we quantified plasma concentrations of soluble total RANKL and OPG in HIV-infected and HIV-negative individuals.”
BackgroundGuaraldi, G., Orlando, G., Zona, S., Menozzi, M., Carli, F., Garlassi, E., Berti, A., Rossi, E., Roverato, A., & Palella, F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir627 · Cited by 1,331 · cited 1×
“Non-AIDS conditions including cardiovascular disease, metabolic disorders, fragility bone disease, and malignancies now account for majority of HIV related morbidity and mortality [1,2].”
BackgroundEstrogen deficiency and bone loss: an inflammatory tale
Weitzmann, M. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28550 · Cited by 990 · cited 1×
“By contrast, under inflammatory conditions both B and T cells can be considerable sources of the proresorptive cytokine, RANKL [21,22].”
BackgroundSelf-citationRole of RANK ligand in mediating increased bone resorption in early postmenopausal women
Eghbali-Fatourechi, G., Khosla, S., Sanyal, A., Boyle, W. J., Lacey, D. L., & Riggs, B. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17215 · Cited by 825 · cited 1×
“RANKL was quantified by incubation with 5 mg/ml recombinant OPG-Fc (R&D systems) for 30 minutes at 4uC as previously described [43], followed by antihuman IgG Fc-PE (BD Biosciences) for another 30 minutes at 4uC.”
MethodAccelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy
Tebas, P., Powderly, W. G., Claxton, S., Marin, D., Tantisiriwat, W., Teitelbaum, S. L., & Yarasheski, K. E. (2000) · AIDS · doi:10.1097/00002030-200003100-00005 · Cited by 532 · cited 1×
“example, skeletal decline has long been recognized in this population [3,4] and data suggest that up to 67% of HIV infected individuals are osteopenic with as many as 15% being osteoporotic [4].”
BackgroundLi, Y., Toraldo, G., Li, A., Yang, X., Zhang, H., Qian, W.-P., & Weitzmann, M. N. (2007) · Blood · doi:10.1182/blood-2006-07-037994 · Cited by 520 · cited 2×
“Bone loss was rescued in these B cell deficient animals by reconstitution of B cells [26].”
BackgroundSelf-citationYun, T. J., Chaudhary, P. M., Shu, G. L., Frazer, J. K., Ewings, M. K., Schwartz, S. M., Pascual, V., Hood, L. E., & Clark3, E. A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6113 · Cited by 307
Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans
Womack, J. A., Goulet, J. L., Gibert, C., Brandt, C., Chang, C. C., Gulanski, B., Fraenkel, L., Mattocks, K., Rimland, D., Rodriguez-Barradas, M. C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017217 · Cited by 261 · cited 1×
“prevalences two- to five-fold higher than the general population have been reported in a number of large observational cohorts [11–16].”
BackgroundDecreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy
Bruera, D., Luna, N., David, D. O., Bergoglio, L. M., & Zamudio, J. (2003) · AIDS · doi:10.1097/00002030-200309050-00010 · Cited by 240 · cited 1×
“Of note, ART actually inflicts an additional 2%–6% loss in bone mineral density (BMD) within the first year or two of therapy initiation [5], further worsening the already compromised skeletal status resulting from HIV infection itself [6,7].”
Background
Cited by
Understanding the Bone in Cancer Metastasis
Fornetti, J., Welm, A. L., & Stewart, S. A. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3618 · Cited by 526
Immunology of Osteoporosis: A Mini-Review
Pietschmann, P., Mechtcheriakova, D., Meshcheryakova, A., Föger-Samwald, U., & Ellinger, I. (2016) · Gerontology · doi:10.1159/000431091 · Cited by 287
Inflammation, mesenchymal stem cells and bone regeneration
Liu, H., Li, D., Zhang, Y., & Li, M. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1643-3 · Cited by 160
Interactions of B-lymphocytes and bone cells in health and disease
Grčević, D., Sanjay, A., & Lorenzo, J. (2023) · Bone · doi:10.1016/j.bone.2021.116296 · Cited by 36
Schistosome infection promotes osteoclast-mediated bone loss
Li, W., Wei, C., Xu, L., Yu, B., Chen, Y., Lu, D., Zhang, L., Song, X., Dong, L., Zhou, S., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009462 · Cited by 22
“However, in pathological conditions such as rheumatoid arthritis and HIV infection, other cells including T cells and B cells are likely to be major contributors to increased pathogenic RANKL production [37,38].”
Background
Metadata
- Authors
- Titanji, K., Vunnava, A., Sheth, A. N., Delille, C., Lennox, J. L., Sanford, S. E., Foster, A., Knezevic, A., Easley, K. A., Weitzmann, M. N., & Ofotokun, I.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-11-13
- Volume
- 10
- Issue
- 11
- Pages
- e1004497
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- OpenAlex
- W2044074653
- Cited by
- 132
- References
- 11
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.